Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis

Current Problems in Pediatric and Adolescent Health Care

Volumn 26, Issue 9, 1996, Pages 318-324

  Nelson, Audrey M ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CLASSIFICATION; EOSINOPHILIA; FASCIITIS; FEMALE; HUMAN; LOCALIZED SCLERODERMA; MALE; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

CHILD; EOSINOPHILIA; FASCIITIS; FEMALE; HUMANS; MALE; PROGNOSIS; SCLERODERMA, LOCALIZED;

EID: 0030255298     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0045-9380(96)80011-9     Document Type: Article

References (46)

1. Falanga V. Fibrosing conditions in childhood. Adv Dermatol 1991;6:145-59.
2. Doyle JA, Connolly SM, Winkelmann RK. Cutaneous and subcutaneous inflammatory sclerosis syndromes. Arch Dermatol 1982;! 18:886-90.
3. Falanga V. Localized scleroderma. Med Clin North Am 1989;73(5):1143-56.
4. Uziel Y, Krafchik BR, Silverman ED, et al. Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum 1994;23(5):328-40.
5. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome [abstract]? J Rheumatol 1974;l(suppl):46.
6. Shulman LE. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 1975;88:70-86.
7. Rodnan GP, DiBartolomeo AG, Medsger TA, et al. Eosinophilic fasciitis-report of seven cases of a newly recognized scleroderma-like syndrome. Clin Res 1975;23:443A.
8. Peterson LS, Nelson AM, Su WPD. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995;70:1068-76.
9. Christianson HB, Dorsey CS, O'Leary PA, et al. Localized scleroderma: a clinical study of two hundred thirty-five cases. Arch Dermatol 1956;74:629-39
10. Miller JJ. The fasciitis-morphea complex in children. Am J Dis Child 1992;145:733-6.
11. Lakhanpal S, Ginsburg WW, Michel CJ, et al. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988;17(4):221-31.
12. Daoud MS, SuWPD, Leiferman KM, et al. Bullous morphea: clinical, pathological, and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994;30(6):937-43.
13. Chung MH, Sum J, Morrell MJ, et al. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995;37:679-81.
14. Goldenstein-Schainberg C, Pereira RMR, Gusukuma MC, et al. Childhood linear scleroderma en coup de sabre with uveitis. J Pediatr 1990;117(4):581-4.
15. David J, Wilson J, Woo P. Scleroderma en coup de sabre. Ann Rheum Dis 1991;50:260-2.
16. Seow WK, Young W. Localized scleroderma in childhood: review of the literature and case report. Pediatr Dent 1987;9(3):240-4.
17. Campbell WW, Bajandas FJ. Restrictive ophthalmopathy associated with linear scleroderma. J Neuroophthalmol 1995;15(2):95-7.
18. Tang RA, Mewis-Christmann L, Wolf J, et al. Pseudo oculomotor palsy as the presenting sign of linear scleroderma. J Pediatr Ophthalmol Strabismus 1986;23:236-8.
19. Suttorp-Schulten MS A, Koornneef L. Linear scleroderma associated with ptosis and motility disorders. BrJ Ophthalmol 1990;74:694-5.
20. Serup J, Alsbirk PH. Localized scleroderma en coup de sa-bre and iridopalpebral atrophy at the same line. Acta Derm Venereol (Stockh) 1983;63:75-7.
21. Lewkonia RM, Lowry RB. Progressive hemifacial atrophy (Parry-Romberg syndrome) report with review of genetics and nosology. Am J Med Genet 1983;14:385-90.
22. Su WPD, Person JR. Morphea profunda: a new concept and a histopathologic study of 23 cases. Am J Dermatopathol 1981;3(3):251-60.
23. Diaz-Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children. Arch Dermatol 1980;! 16:169-73.
24. Person JR, Su WPD. Subcutaneous morphoea: a clinical study of sixteen cases. Br J Dermatol 1979;100:371-80.
25. Peterson LS, Nelson AM, Su WPD, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 19601993 [abstract]. Arthritis Rheum 1995;38 Suppl:S333.
26. Levinson JE, Bove KE. In: Gershwin ME, Robbins DE, editors. Musculoskeletal disease of children. Orlando: Grime & Stratton, 1983:195-208.
27. Takehara K, Moroi Y, Nakabayashi Y, et al. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983;26(5)612-6.
28. Rosenberg AM, Uziel Y, Krafchik BR. Antinuclear antibodies in children with localized scleroderma. J Rheumatol 1995;22:2337-43.
29. Woo TY, Rasmussen JE. Juvenile linear scleroderma associated with sérologie abnormalities. Arch Dermatol 1985;121:1403-5.
30. Sato S, Fujimoto M, Ihn H, et al. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 1994;31:567-71.
31. Sato S, Ihn H, Soma Y, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993;36(8):1137-41.
32. Falanga V, Medsger TA, Reichlin M, et al. Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 1986;104:849-57.
33. Fujimoto M, Sato S, Ihn H, et al. Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis. J Rheumatol 1995;22:563-5.
34. Jablonska S. Localized scleroderma. In: Jablonska S, editor. Scleroderma and pseudoscleroderma. Warsaw: Polish Medical Publications, 1975:277-303.
35. Morell A, Betlloch I, Sevila A, et ai. Morphea-like reaction from vitamin K,. Int J Dermatol 1995;34(3)201-2.
36. Aberer E, Neumann R, Stanek G. Is localized scleroderma a Borrelia infection [letter]? Lancet 1985;2:278.
37. Aberer E, Stanek G, Ertl M, et al. Evidence for spirochetal origin of circumscribed scleroderma (morphea). Acta Derm Venereol (Stockh) 1987;67:225-3I.
38. Aberer E, Klade H, Stanek G, et al. Borrelia burgdorferi and different types of morphea. Dermatologica 1991;182:14554.
39. Fan W, Leonardi CL, Penneys NS. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea). J Am Acad Dermatol 1995;33:682-4.
40. Dillon WI, Saed GM, Fi venson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995;33(4):6I7-20.
41. Birdi N, Laxer RM, Thorner P, et al. Localized scleroderma progressing to systemic disease. Arthritis Rheum 1993;36(3)410-5.
42. Mayorquin FJ, McCurley TL, Levernier JE, et al. Progrès-sion of childhood linear scleroderma to fatal systemic sclerosis. J Rheumatol 1994;21:1955-7.
43. Dehen L, Roujeau J, Cosnes A, et al. Internal involvement in localized scleroderma. Medicine 1994;73(5):241-5.
44. Krafchik BR. Localized cutaneous scleroderma. Semin Dermatol 1992;11(l):65-72.
45. Janzen L, Jeffery JR, Gough J, et al. Response to methotrexate in a patient with idiopathic eosinophilic fasciitis, morphea, IgM hypergammaglobulinemia, and renal involvement. J Rheumatol 1995;22:1967-70.
46. Al-Shaikh A, Freeman C, Avruch L, et al. Use of magnetic resonance imaging in diagnosing eosinophilic fasciitis. Arthritis Rheum 1994;37(11):1602-8.